Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedRevision metadata on the page was updated from v3.6.0 to v3.6.2. This reflects a newer release of the page framework rather than a change to the study content.SummaryDifference0.0%

- Check13 days agoChange DetectedMultiple entries in the Study Documents section were deleted, removing access to key documents such as the Statistical Analysis Plan, Study Protocol, Informed Consent Form, IPD Sharing information, and related materials. This change reduces the transparency and accessibility of essential trial documentation for reviewers and participants.SummaryDifference20%

- Check20 days agoChange DetectedThe study page now shows No longer looking for participants to indicate that recruitment has ended; new navigation/help items such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and minor formatting updates include standardizing the Intervention/Treatment heading and updating the Revision label to v3.6.0.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a small update to the page's metadata/presentation rather than any substantive study information.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded explicit disease context by listing 'Multiple myeloma' and a related topics entry for MedlinePlus Genetics.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a bibliographic citation for the DREAMM-2 publication with full bibliographic details and identifiers, and updated the revision label to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.